Health Care & Life Sciences » Biotechnology | Capricor Therapeutics Inc.

Capricor Therapeutics Inc. | Ownership

Companies that own Capricor Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Brown Advisory LLC
1,136,755
3.7%
0
0%
06/30/2018
The Vanguard Group, Inc.
782,824
2.54%
76,191
0%
06/30/2018
LLBH Private Wealth Management LLC
119,591
0.39%
0
0.06%
06/30/2018
Geode Capital Management LLC
118,686
0.39%
41,690
0%
06/30/2018
Virtu Financial BD LLC
56,760
0.19%
4,350
0%
06/30/2018
Apriem Advisors
50,000
0.16%
0
0.01%
06/30/2018
Northern Trust Investments, Inc.
45,919
0.15%
7,259
0%
06/30/2018
BlackRock Fund Advisors
40,825
0.13%
36,706
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
25,097
0.08%
0
0%
06/30/2018
Acadian Asset Management LLC
11,949
0.04%
-48,804
0%
06/30/2018

About Capricor Therapeutics

View Profile
Address
8840 Wilshire Boulevard
Beverly Hills California 90211
United States
Employees -
Website http://www.capricor.com
Updated 07/08/2019
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.